Abstract
The present study examines the functional and binding affinities of the aporphine alkaloid, (+)-boldine, at different α 1- and α 2-adrenoceptor subtypes, namely, α 1A (rat vas deferens and kidney) and its L-like state (rabbit spleen), α 1B (guinea pig spleen, mouse spleen and rabbit aorta), α 1D (rat aorta and pulmonary artery), at possible subtypes of prejunctional α 2-adrenoceptors in rat and rabbit vas deferens and rat atrium, α 2D in guinea pig ileum, cloned human α 1-adrenoceptor subtypes A, B and D and α 2-adrenoceptor subtypes A, B and C as well as rat α 2D-adrenoceptors. Additionally, we investigated its Ca 2+ channel antagonism in vascular and cardiac preparations. (+)-Boldine had higher affinity at α 1-adrenoceptor subtype A (p A 2=7.46, p K i=7.21) compared with its L-like state (p A 2=5.63) or subtype B (p A 2=5.98– 6.12, p K i=5.79) and subtype D (p A 2=6.18–6.37, p K i=6.09). Its affinities at α 2-adrenoceptors in rat and rabbit vas deferens and rat atrium (p A 2=6.02, 6.36, 6.06, respectively) were identical, but lower at guinea pig ileum α 2D-adrenoceptors (p A 2=4.38). (+)-Boldine displayed nearly undistinguishable affinity at cloned human α 2-adrenoceptor subtypes A, B and C (p K i=6.26, 5.79 and 6.35, respectively), whereas its affinity at rat α 2D-adrenoceptors was low (p K i=4.70). In perfused rat kidney, (+)-boldine inhibited K +-evoked vasoconstriction at doses 70-fold higher than diltiazem. In guinea pig Langendorff heart, (+)-boldine (10 −5–2×10 −4 M) was equieffective in increasing coronary flow and in depressing cardiac force, while lower concentrations already depressed heart rate. In papillary muscles from guinea pig, (+)-boldine (10 −6–10 −5 M) mainly prolonged the duration of action potential at levels >30% of repolarization. These data reveal that (+)-boldine, except for its moderate selectivity (15 to 25-fold) for α 1A-adrenoceptors, does not discriminate between the α 1-adrenoceptor subtypes B and D and α 2-adrenoceptor subtypes A, B and C, at which the drug consistently displays micromolar affinity. In vascular and cardiac preparations, (+)-boldine, although being at least 50-fold weaker than diltiazem, shows Ca 2+ channel antagonistic properties but no specificity for coronary dilatation relative to cardiodepression.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.